Geron Rises as Imetelstat Helps Against Myelofibrosis - Bloomberg
This is an article about the drug company Geron. Its shares have tripled this year, and more gains are probably ahead. I own the stock also.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment